Meeting New People and Finding Old Assumptions After Cancer

September 23rd 2024, 5:00pm

By Karen Cohn

Recently, I met a fellow cancer survivor but after talking with her about cancer, I realized she had a different perspective than I did.

Steatotic Liver Disease Linked to Improved Survival in Patients With Liver Cancer

September 23rd 2024, 3:00pm

By Spencer Feldman

Steatotic liver disease was associated with better liver function, lower recurrence rates, and improved overall survival in patients with liver cancer who received radiofrequency ablation.

Enhertu Maintains QOL, Slows Pain in HR+/HER2 Metastatic Breast Cancer

September 23rd 2024, 1:00pm

By Jonah Feldman

Enhertu improved the time it took for patients with a breast cancer subset to experience worsening pain and other symptoms, without affecting overall quality of life.

Patients with Extensive-Stage SCLC May Benefit From Higher I-DXd Dose

September 22nd 2024, 3:00pm

By Ashley Chan

A recent study compared two dosages of ifinatamab deruxtecan among patients with extensive-stage small cell lung cancer.

My Daughter Talked Through Her Eyes During Cancer

September 21st 2024, 6:00pm

By Mark Younce

When my daughter couldn't express her words while she received treatment for brain cancer, her eyes told me everything I needed to know.

Challenges to Consider While Receiving Fotivda for Kidney Cancer

September 21st 2024, 2:00pm

By Ashley Chan

At the 2024 ESMO Congress, CURE® spoke with an expert about Fotivda and certain challenges patients may experience, such as side effects.

FDA Approves Sarclisa In Newly Diagnosed Transplant-Ineligible Multiple Myeloma

September 20th 2024, 8:11pm

By Alex Biese

The Food and Drug Administration has approved Sarclisa as a first-line treatment for patients with multiple myeloma who are ineligible for autologous stem cell transplant.

Keytruda Improves Disease-Free Survival in Some With Urothelial Carcinoma

September 20th 2024, 7:00pm

By Tony Berberabe, M.P.H.

Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived without signs of cancer.

In a World of Rushing, Cancer Taught Me to Slow Down

September 20th 2024, 5:00pm

By Jane Biehl Ph.D.

With my myelodysplastic syndrome and age, I find it hard to keep up; however, cancer and fatigue have taught me to live at my own pace.

Swimsuit Model Reveals Ovarian Cancer, Hockey Pro Shares Diagnosis and More

September 20th 2024, 3:00pm

By Alex Biese

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in the oncology space this week.

Survival Rate Increased With Yervoy-Opdivo Combo in Kidney Cancer

September 20th 2024, 1:00pm

By Kyle Doherty

The 12-month survival rates in patients with non-clear cell renal cell carcinoma showed improvements after treatment with Yervoy plus Opdivo.

The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration

September 20th 2024, 12:59pm

The discussion will wrap up with perspectives on the future of CLL treatment, including anticipated improvements in patient care and quality of life, emerging therapies, and evolving patient roles in care decisions.

Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors

September 20th 2024, 12:57pm

The discussion will explore the impact of fixed-duration treatments on quality of life, benefits and challenges compared with continuous therapy, financial considerations, and lifestyle goals during and after treatment.

Rybrevant Plus Chemo Approved by FDA in Lung Cancer Subset

September 19th 2024, 11:05pm

By Ashley Chan

The FDA has approved Rybrevant plus chemotherapy in certain patients with locally advanced or metastatic non-small cell lung cancer.

Study Confirms Lenvima’s Benefits in Thyroid Cancer

September 19th 2024, 9:00pm

By Morgan Bayer

First-time treatment with Lenvima continues to outperform other treatments for thyroid cancer.